These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31619891)

  • 21. Temporal fossa defects: techniques for injecting hyaluronic acid filler and complications after hyaluronic acid filler injection.
    Juhász ML; Marmur ES
    J Cosmet Dermatol; 2015 Sep; 14(3):254-9. PubMed ID: 26311237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemic oculomotor nerve palsy due to hyaluronic acid filler injection.
    Bae IH; Kim MS; Choi H; Na CH; Shin BS
    J Cosmet Dermatol; 2018 Dec; 17(6):1016-1018. PubMed ID: 29607622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Hyaluronic Acid Filler-Induced Impending Necrosis With Hyaluronidase: Consensus Recommendations.
    Cohen JL; Biesman BS; Dayan SH; DeLorenzi C; Lambros VS; Nestor MS; Sadick N; Sykes J
    Aesthet Surg J; 2015 Sep; 35(7):844-9. PubMed ID: 25964629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infraorbital Hollow Rejuvenation: Considerations, Complications, and the Contributions of Midface Volumization.
    Woodward J; Cox SE; Kato K; Urdiales-Galvez F; Boyd C; Ashourian N
    Aesthet Surg J Open Forum; 2023; 5():ojad016. PubMed ID: 36998744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection.
    Davidova P; Müller M; Wenner Y; König C; Kenikstul N; Kohnen T
    Am J Ophthalmol Case Rep; 2022 Jun; 26():101407. PubMed ID: 35243152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronidase: An overview of its properties, applications, and side effects.
    Jung H
    Arch Plast Surg; 2020 Jul; 47(4):297-300. PubMed ID: 32718106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperbaric oxygen therapy for dermal ischemia after dermal filler injection with calcium hydroxylapatite: a case report.
    Uittenbogaard D; Lansdorp CA; Bauland CG; Boonstra O
    Undersea Hyperb Med; 2019 Mar-Apr-May; 46(2):207-210. PubMed ID: 31051067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature.
    Kassir R; Kolluru A; Kassir M
    J Cosmet Dermatol; 2011 Sep; 10(3):224-31. PubMed ID: 21896135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Intra-arterial Hyaluronidase Infusion for Ophthalmic Artery Occlusion Following Cosmetic Facial Filler (Hyaluronic Acid) Injection.
    Oh BL; Jung C; Park KH; Hong YJ; Woo SJ
    Neuroophthalmology; 2014; 38(1):39-43. PubMed ID: 27928273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.
    Juhász MLW; Levin MK; Marmur ES
    Dermatol Surg; 2017 Jun; 43(6):841-847. PubMed ID: 28498207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Retrobulbar Hyaluronidase in Filler-Associated Blindness: Evaluation of Fundus Perfusion and Electroretinogram Readings in an Animal Model.
    Hwang CJ; Mustak H; Gupta AA; Ramos RM; Goldberg RA; Duckwiler GR
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):33-37. PubMed ID: 29877958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tear trough rejuvenation: A safety evaluation of the treatment by a semi-cross-linked hyaluronic acid filler.
    Berguiga M; Galatoire O
    Orbit; 2017 Feb; 36(1):22-26. PubMed ID: 28121477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical experience with complications of hand rejuvenation.
    Park TH; Yeo KK; Seo SW; Kim JK; Lee JH; Park JH; Rah DK; Chang CH
    J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1627-31. PubMed ID: 22763320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional hyaluronidase injection to relieve non-hyaluronic acid filler-induced vascular adverse events.
    Kadouch J; Schelke L; Groh O; Sokol V; Velthuis P
    Int J Dermatol; 2024 Jul; ():. PubMed ID: 38955457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An In Vitro Model Assessing the Penetration of Hyaluronidase through Optic Nerve Dura for Management of Hyaluronic Acid Facial Filler Embolism.
    Adulkar N; Cheng C; Lee L; Rasmussen S; Dolman PJ; Yin VT
    Plast Reconstr Surg; 2019 Jul; 144(1):43e-47e. PubMed ID: 31246809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience and Management of Intravascular Injection with Facial Fillers: Results of a Multinational Survey of Experienced Injectors.
    Goodman GJ; Roberts S; Callan P
    Aesthetic Plast Surg; 2016 Aug; 40(4):549-55. PubMed ID: 27286849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demarcative Necrosis Along Previous Laceration Line After Filler Injection.
    Kim JL; Shin JY; Roh SG; Lee NH
    J Craniofac Surg; 2017 Jul; 28(5):e481-e482. PubMed ID: 28665851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doppler Ultrasound in the Management of Vascular Complications Associated with Hyaluronic Acid Dermal Fillers.
    Munia MA; Munia CG; Parada MB; Ben-Hurferraz Parente J; Wolosker N
    J Clin Aesthet Dermatol; 2022 Feb; 15(2):40-43. PubMed ID: 35309877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized comparison of the efficacy of low volume deep placement cheek injection vs. mid- to deep dermal nasolabial fold injection technique for the correction of nasolabial folds.
    Goodier M; Elm K; Wallander I; Zelickson B; Schram S
    J Cosmet Dermatol; 2014 Jun; 13(2):91-8. PubMed ID: 24910271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-filler vascular occlusion: a cautionary tale and emphasis for early intervention.
    McGuire LK; Hale EK; Godwin LS
    J Drugs Dermatol; 2013 Oct; 12(10):1181-3. PubMed ID: 24085057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.